Medico Remedies Secures INR 37 Crore Order from UP Medical Supplies
Filing Summary
Medico Remedies Ltd has received an order valued at approximately INR 37 Crore from Uttar Pradesh Medical Supplies Corporation Limited. The order involves the supply of multiple drugs and is scheduled for completion by October 31, 2026. This transaction is governed by Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. The order is domestic, and there are no related party transactions involved. Medico Remedies has no promoter interest in the awarding entity. This development aligns with the company’s focus on expanding its government supply contracts.
On January 26, 2026, Medico Remedies Ltd announced the receipt of a significant order from Uttar Pradesh Medical Supplies Corporation Limited. The order is valued at approximately INR 37,17,62,439 and involves the supply of multiple drugs. The completion date for the supply is set for October 31, 2026.
The order was awarded under the guidelines of Regulation 30, read with Part B of Schedule III, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The order is domestic, and Medico Remedies has confirmed that there are no related party transactions or promoter interests involved in this contract.
The Uttar Pradesh Medical Supplies Corporation Limited is a government entity responsible for the centralized purchase and distribution of medicines and health supplies in Uttar Pradesh. The corporation aims to provide timely and effective healthcare services across the state. This order is part of its ongoing efforts to ensure the availability of essential drugs and medical supplies.
Medico Remedies Ltd is focused on expanding its footprint in the pharmaceutical supply sector, particularly in government contracts. The company specializes in the production and distribution of pharmaceutical products, aiming to meet the growing demand for healthcare supplies in India. This order from Uttar Pradesh Medical Supplies Corporation Limited aligns with Medico Remedies’ strategic priorities in the healthcare sector.